Home/ Stocks/ QDEL

QuidelOrtho Corporation Common Stock

QDEL XNAS

$10.80 +0.08 (+0.74%) ▲ 15-min delayed

Open

$10.67

High

$11.27

Low

$10.43

Volume

2.15M

Market Cap

$736.46M

About QuidelOrtho Corporation Common Stock

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.

Sector: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES Employees: 6.5K Website →

Key Financials

Period	Revenue	Net Income	EPS
Q4 2026	$619.80M	$-91,800,000	$-1.35
FY 2025	$2.73B	$-1,131,800,000	$-16.69
Q3 2025	$699.90M	$-733,000,000	$-10.78
Q2 2025	$613.90M	$-255,400,000	$-3.77

Earnings & Analyst Ratings

Next Earnings: Mon, Aug 3, 2026

Calendar →

Related Market News

No specific coverage for QDEL yet. Check out our latest market news or earnings calendar.

Get QDEL Alerts

Stay ahead with breaking news, price alerts, and expert analysis on QuidelOrtho Corporation Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.